Schleicher S - Search Results

1

In the Absence of a TCR Signal IL-2/IL-12/18-Stimulated γδ T Cells Demonstrate Potent Anti-Tumoral Function Through Direct Killing and Senescence Induction in Cancer Cells.

Schilbach K, Welker C, Krickeberg N, Kaißer C, Schleicher S, Hashimoto H. Schilbach K, et al. Among authors: schleicher s. Cancers (Basel). 2020 Jan 4;12(1):130. doi: 10.3390/cancers12010130. Cancers (Basel). 2020. PMID: 31947966 Free PMC article.

2

Cancer-targeted IL-12 controls human rhabdomyosarcoma by senescence induction and myogenic differentiation.

Schilbach K, Alkhaled M, Welker C, Eckert F, Blank G, Ziegler H, Sterk M, Müller F, Sonntag K, Wieder T, Braumüller H, Schmitt J, Eyrich M, Schleicher S, Seitz C, Erbacher A, Pichler BJ, Müller H, Tighe R, Lim A, Gillies SD, Strittmatter W, Röcken M, Handgretinger R. Schilbach K, et al. Among authors: schleicher s. Oncoimmunology. 2015 Mar 19;4(7):e1014760. doi: 10.1080/2162402X.2015.1014760. eCollection 2015 Jul. Oncoimmunology. 2015. PMID: 26140238 Free PMC article.

3

GD2-targeted chimeric antigen receptor T cells prevent metastasis formation by elimination of breast cancer stem-like cells.

Seitz CM, Schroeder S, Knopf P, Krahl AC, Hau J, Schleicher S, Martella M, Quintanilla-Martinez L, Kneilling M, Pichler B, Lang P, Atar D, Schilbach K, Handgretinger R, Schlegel P. Seitz CM, et al. Among authors: schleicher s. Oncoimmunology. 2019 Nov 7;9(1):1683345. doi: 10.1080/2162402X.2019.1683345. eCollection 2020. Oncoimmunology. 2019. PMID: 32002293 Free PMC article.

4

Cytotoxic drugs in combination with the CXCR4 antagonist AMD3100 as a potential treatment option for pediatric rhabdomyosarcoma.

Regenbogen S, Stagno MJ, Schleicher S, Schilbach K, Bösmüller H, Fuchs J, Schmid E, Seitz G. Regenbogen S, et al. Among authors: schleicher s. Int J Oncol. 2020 Jul;57(1):289-300. doi: 10.3892/ijo.2020.5059. Epub 2020 May 5. Int J Oncol. 2020. PMID: 32377699

5

Adapter Chimeric Antigen Receptor (AdCAR)-Engineered NK-92 Cells for the Multiplex Targeting of Bone Metastases.

Grote S, Traub F, Mittelstaet J, Seitz C, Kaiser A, Handgretinger R, Schleicher S. Grote S, et al. Among authors: schleicher s. Cancers (Basel). 2021 Mar 5;13(5):1124. doi: 10.3390/cancers13051124. Cancers (Basel). 2021. PMID: 33807875 Free PMC article.

6

The Effect of Direct and Indirect EZH2 Inhibition in Rhabdomyosarcoma Cell Lines.

Schmidt A, Behrendt L, Eybe J, Warmann SW, Schleicher S, Fuchs J, Schmid E. Schmidt A, et al. Among authors: schleicher s. Cancers (Basel). 2021 Dec 23;14(1):41. doi: 10.3390/cancers14010041. Cancers (Basel). 2021. PMID: 35008205 Free PMC article.

7

T_H1 cytokines induce senescence in AML.

Hashimoto H, Güngör D, Krickeberg N, Schmitt J, Doll L, Schmidt M, Schleicher S, Criado-Moronati E, Schilbach K. Hashimoto H, et al. Among authors: schleicher s. Leuk Res. 2022 Jun;117:106842. doi: 10.1016/j.leukres.2022.106842. Epub 2022 Apr 26. Leuk Res. 2022. PMID: 35490594 Free article.

8

Novel adapter CAR-T cell technology for precisely controllable multiplex cancer targeting.

Seitz CM, Mittelstaet J, Atar D, Hau J, Reiter S, Illi C, Kieble V, Engert F, Drees B, Bender G, Krahl AC, Knopf P, Schroeder S, Paulsen N, Rokhvarguer A, Scheuermann S, Rapp E, Mast AS, Rabsteyn A, Schleicher S, Grote S, Schilbach K, Kneilling M, Pichler B, Lock D, Kotter B, Dapa S, Miltenyi S, Kaiser A, Lang P, Handgretinger R, Schlegel P. Seitz CM, et al. Among authors: schleicher s. Oncoimmunology. 2021 Dec 2;10(1):2003532. doi: 10.1080/2162402X.2021.2003532. eCollection 2021. Oncoimmunology. 2021. PMID: 35686214 Free PMC article.

9

In Vitro Evaluation of CD276-CAR NK-92 Functionality, Migration and Invasion Potential in the Presence of Immune Inhibitory Factors of the Tumor Microenvironment.

Grote S, Ureña-Bailén G, Chan KC, Baden C, Mezger M, Handgretinger R, Schleicher S. Grote S, et al. Among authors: schleicher s. Cells. 2021 Apr 26;10(5):1020. doi: 10.3390/cells10051020. Cells. 2021. PMID: 33925968 Free PMC article.

10

Preclinical Evaluation of CRISPR-Edited CAR-NK-92 Cells for Off-the-Shelf Treatment of AML and B-ALL.

Ureña-Bailén G, Dobrowolski JM, Hou Y, Dirlam A, Roig-Merino A, Schleicher S, Atar D, Seitz C, Feucht J, Antony JS, Mohammadian Gol T, Handgretinger R, Mezger M. Ureña-Bailén G, et al. Among authors: schleicher s. Int J Mol Sci. 2022 Oct 24;23(21):12828. doi: 10.3390/ijms232112828. Int J Mol Sci. 2022. PMID: 36361619 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

136 results

Search Page